SARS-CoV-2/Flu A/FLu B/RSV/ADV/MP Antigen Rapid Test Kits

$29.991 Test/Box

Intended Use

The visual reading test kit is a rapid, qualitative diagnostic tool designed for the simultaneous detection of antigens from six major respiratory pathogens: SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Adenovirus, and Mycoplasma pneumoniae. This test is intended for use with throat swab specimens collected from individuals exhibiting symptoms of respiratory tract infections, such as cough, fever, sore throat, or difficulty breathing.

The primary purpose of this six-in-one respiratory panel is to provide accurate and timely identification of the causative pathogen responsible for respiratory illnesses. By detecting specific antigens associated with these pathogens, the kit aids in differentiating between viral and bacterial infections, enabling healthcare providers to make informed decisions regarding treatment and infection control measures.

This test is particularly valuable in clinical settings, such as hospitals, outpatient clinics, and emergency departments, where rapid diagnosis is critical for patient management and preventing the spread of infectious diseases. It is also suitable for use in point-of-care (POC) settings, such as your doctor office or at-home testing, offering results within 15–20 minutes without the need for specialized laboratory equipment.

 

 

Timely and accurate diagnostic testing not only improves patient outcomes but also informs public health initiatives and targeted interventions. This necessity becomes more apparent during outbreaks or pandemics, like COVID-19 and other air-borne viruses or bacteria when rapid testing is essential for identifying cases, implementing containment measures, and allocating resources. Diagnostic testing provides reliable data for evidence-based decision-making, crucial for mitigating the impact of infectious diseases on individuals and communities.